News - MedTech & Diagnostics
Healthscope’s collapse sparks urgent calls for oversight amid fears for patient care and workforce

As Healthscope, Australia’s second-largest private hospital group, enters receivership, healthcare leaders are sounding the alarm on the potential fallout for patients, staff, and the broader health system.
The Australian Medical Association (AMA) and the Australian Nursing and Midwifery Federation (ANMF) have voiced serious concerns about the management of the collapse and its ramifications for continuity of care.
With private hospitals delivering approximately 70% of all elective surgeries in Australia and supported by around $8 billion in taxpayer funds through the private health insurance rebate, the stability of the sector is now under scrutiny.
“The Healthscope network of hospitals is a key part of private healthcare delivery in Australia,” said AMA President Dr Danielle McMullen. “The situation that has emerged with respect to Healthscope further reinforces the need to adopt the AMA’s proposal for an independent Private Health System Authority giving much better oversight of the sector.”
Each year, more than 650,000 Australians receive care through Healthscope’s 38 hospitals, which collectively employ around 19,000 healthcare professionals and support staff. The collapse has prompted assurances from the federal government.
Minister for Health and Aged Care Mark Butler MP acknowledged the potential domino effect on the public hospital system if the sale of Healthscope assets is not carefully managed.
“A disorderly process [of Healthscope sale] would have an impact on public hospitals… that’s why we’ve been so determined to make sure that [the] sale of Healthscope hospitals [is] undertaken in an orderly, stable way that protects the operations of those hospitals, and through that the interests of patients and the very hard-working staff members,” Minister Butler said.
ANMF Federal Secretary Annie Butler echoed the concerns for the workforce, noting that while staff have been reassured for now, anxiety remains high.
“For nurses and midwives working at Healthscope, this situation is obviously very difficult and worrying for them and our thoughts are with them. However, we have been assured that their jobs and their patients are secure at this time,” she said.
The ANMF has requested urgent briefings with Healthscope’s management and the Receiver, and has been promised priority meetings. Still, the union sees the collapse as symptomatic of deeper issues in the health system.
“The financial collapse of Healthscope is a shocking reminder about the dangers of privatising healthcare services and that Americanised health care does not work in Australia,” Butler said. “We will also be urging the Government to review the types of companies they allow to participate in the delivery of health services and prevent unethical and unscrupulous parties, which have no regard for patients or the health workforce, from entering the system.”
Despite the turmoil, Minister Butler confirmed that the collapse would not derail progress on the National Health Reform Agreement (NHRA).
“We’re starting to put ourselves in a position as a re-elected government to start those negotiations again,” Minister Butler said.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - Pharmaceuticals

HTA Review IAG sharpens focus on environmental impact
As Australia’s healthcare sector faces growing scrutiny over its contribution to greenhouse gas emissions, momentum is building to embed environmental […]
MoreDigital & Innovation

Virtual cardiac program launched to reduce hospital re-admissions
A new partnership between a not-for-profit health insurer and an Australian digital health company is set to transform cardiac care […]
MoreNews - Pharmaceuticals

Australian researcher wins global Gilead grant for repurposed drug in breast cancer
A Monash University scientist has been named one of only three researchers globally to receive the 2025 Gilead Sciences Research […]
MoreNews - MedTech & Diagnostics

Australian-backed medtech hits first commercial milestone with world-first heart device
The only medical technology to deliver leadless left ventricular endocardial pacing (LVEP) for heart failure has secured initial US reimbursement, […]
More